SADC Industrialisation Week 2017 - Post Event Information

Working Group
PUBLIC PROFILE

R&D, Innovation and Intellectual Property in Health & Pharma

Posted by Janice Scheckter on 10 August 2017 11:50 AM SAST
Janice Scheckter photo

Moderator: Ms Anneline Morgan, Science, Technology and Innovation, SADC Secretariat

Dr David Katerere, Lecturer at Tshwane University of Tech. 

Ms Rosemary Wilson, CSIR - involved in issues around IP management and particular interest in supporting policy management. 

Mr Marumo Nkomo, Director Legal ITED, the dti

Ben Anderson, Prof Design Thinking, Da Vinci Institute - will share ideas what is the required thinking to be innovative 

Mr Fernando Dos Santos, Director General, African Regional Intellectual Property Organisation

Ben Anderson, Prof Design Thinking, Da Vinci Institute - will share ideas what is the required thinking to be innovative 

* do we think 'outside the box'

* promoted a cooperative model where there is a high level of agreement and a high level of social interaction. 

Dr David Katerere, Lecturer at Tshwane University of Tech. 

We appear to have a lot of R but no D. And part of the problem is the lack of an ecosystem. An example - we have a gum that will be used for aeroplane ears - but we were unable to find a local gum manufacturer. 

On another project we needed a synthetic chemist but failed to find one. 

Another problem is the lack of incentives. A document out for the CSIR says you should not publish before you patent. because of the time, it takes for patents and of course cost - people may simply publish prior to the patent being accepted. This means that they disclose their IP. 

There also appears to be no co-creation. 

Finally innovation competitions. Pity there is no-one here from the Innovation Hub. 

Ms Rosemary Wilson, CSIR - involved in issues around IP management and particular interest in supporting policy management. 

My job to overcome some of the challenges you mention. It's important in South Africa that we have more capacity. We also have great intent but it doesn't always materialise. Trust or lack thereof is an issue and often the case between public and private sector. In the area particularly of health care and pharma there is a fairly different flow of information. IP may come out of universities or techs for example and then we'd go and look for licensees to take it to market. The concept of socially responsible licencing has come of a lot of late. This is particularly intended to address issues where for example the ultimate beneficiaries are unable to pay. Various ways of going about it:

* should various organisations be patenting - to simply put the IP out in the public domain doesn't always work and sometimes dilutes the value. In Pharma companies will only get involved if they have some exclusive rights. 

* can look at licencing according to certain terms that may include pricing caps for example 

* taking a step from there is the R&D topic - there is new thinking about how you bring in new costing and funding models 

* open innovation paradigm is under utilised 

* we a better combination of 'open source' and proprietary 

* what will be critical is the value of IP and whether it hinders or promotes R&D and innovation

Mr Marumo Nkomo, Director Legal ITED, the dti

In pharma IP is critical. Some would argue that protecting IP rights serves business and not getting medication to those who need it the most. There are of course many other important issues around regulatory, for example. The enforcement around IP rights cannot be reviewed uncritically. 

Let's take a look at countries that have been more strategic around pharma patents. When Switzerland did adopt IP law - it allowed the industry to develop and become innovative. 

Mr Fernando Dos Santos, Director General, African Regional Intellectual Property Organisation (ARIPO) Formed in 1976

Member based organisations mainly Anglo orgs. Vision is to be Africa's IP hub. It came about around the pooling of resources. Promotion, Harmonisation, and Promotion of IP in Africa. Establish IP training. Run a flagship program around Masters of IP. 

Q&A

1. Affiliated to ISO and noting that standards are for sale, because of issues in Intellectual Property. It a patent always 20 years? 

Patents have always been 20 years. 

2. Have far is the policy? 

Been through an extensive process at the dti and we've had to do some serious introspection. Developed in 2016 an IP consultative process.  

3. How does ARIPO/dti see South Africa's position on IP being incorporated? 

Much discussion that IP is only part of the story. David - we're so worried about IP protection but there is a lack of IP here. We need to focus on skills and capacity and then move to IP and IP protection and commercialisation. 

In summary - moderator summing up

* key issues is the policy environment at a national, regional and international level

* from the SADC perspective, one of the action items is to develop an IP policy framework and there is a draft document prepared

* also developed a model template for member states and universities

* ministers have reaffirmed that 1% increase in budget to R&D and the secretariate will continue to monitor

* instruments - how do we establish regional support instruments and how do we create an innovation fund as a region

* skills and dev could not be overemphasised

* as part of the education sector just launch a framework for the region 

* working with UNESCO around SADC TVET sector

* noted that R&D infrastructure is lacking

* emphasise trust between public and private sector

* this event is part of bringing public and private sector together

* ultimately what we're all here for is the vision 2063 

* lastly - what type of partnership models are we negotiating? 

industrialisation, innovation, ip, r&d, sadc

There are no comments

Sign in to add your comment.

Recent Posts

Sunninghill Declaration 2017 Private Sector Communiqué of the Second Annual SADC Industrialization Week
Between 30 July 2017 and 4 August 2017, delegates from the media; private sector; civil society and...
read more
Non-State actors - Civil Society and Business interaction on key Regional Integration Challenge
* Introduction of SADC Industrialisation Strategy and Action Plan * Q&A * Civil Society...
read more
Successful models
1. Monnanne M Monnanne PhD Potential Value Chain identified by the strategy and action plans...
read more
DAY 3 - Made in Africa Day Keynote
Dr Eve Gadzikwa, President of the Regional Standardization Organization Repositioning the SADC...
read more
R&D, Innovation and Intellectual Property in Health & Pharma
Moderator: Ms Anneline Morgan, Science, Technology and Innovation, SADC Secretariat
read more
Case Study in health innovation
Unjani Clinics presented by Ms Lynda Toussaint
read more
What level of cooperation will it take from government, donors and industry to implement SADC's Pharmaceutical Business Plan
Moderator: Dr David Katerere, Tshwane University of Technology
read more
SADC's infrastructure master plan - are we on track?
Mr Joseph Mthetwa, Senior Program Officier, Health and Pharmaceuticals. Moderator.
read more
Feedback of the session led by the OECD foresight group
For group feedbacks please refer to the links below.
read more
Official opening of the SADC Pharmaceutical Business Plan
Dr Lomkhosi Mkhonta-Gama, Acting Director: Industrial Development & Trade, SADC Secretariat
read more

Go to blog